Now showing items 1-1 of 1

    • Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy 

      Pascual, Tomás; Fernandez-Martinez, Aranzazu; Agrawal, Yash; Pfefferle, Adam D.; Chic, Nuria; Brasó-Maristany, Fara; Gonzàlez-Farré, Blanca; Paré, Laia; Villacampa, Guillermo; Saura, Cristina; Hernando, Cristina; Muñoz, Montserrat; Galván, Patricia; Gonzàlez-Farré, Xavier; Oliveira, Mafalda; Gil-Gil, Miguel; Ciruelos, Eva; Villagrasa, Patricia; Gavilá, Joaquín; Prat, Aleix; Perou, Charles M. (npj Breast Cancer, 2024)
      In this study, we performed genomic analyses of cell cycle and tumor microenvironment changes during and after ribociclib and letrozole or chemotherapy in the CORALLEEN trial. 106 women with untreated ...